NCT04134650 Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes Status UNKNOWN Phase PHASE3
NCT04131582 Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes Status UNKNOWN Phase PHASE3
NCT04121468 A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis Status RECRUITING Phase PHASE1/PHASE2
NCT04116203 Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS) Status COMPLETED Phase PHASE1
NCT04114136 Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies Status RECRUITING Phase PHASE2
NCT04089813 Effect of Metformin on Chronic Pain After Thoracic Surgery in Diabetic Patients Status UNKNOWN Phase N/A
NCT04088461 Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine Status COMPLETED Phase PHASE4
NCT04088448 The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04068246 The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04053621 Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes Status UNKNOWN Phase NA
NCT04033107 High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors Status UNKNOWN Phase PHASE2
NCT04029480 Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) Status COMPLETED Phase PHASE3
NCT04029272 Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients Status UNKNOWN Phase PHASE4
NCT04010942 Vitamin D for Polycystic Ovary Syndrome Clomiphene Resistant Women Status COMPLETED Phase PHASE4
NCT04009603 Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS Status COMPLETED Phase NA
NCT04001725 Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases Status UNKNOWN Phase PHASE2
NCT03994744 Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC Status UNKNOWN Phase PHASE2
NCT03982381 SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT03982238 Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4